1,349
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Drugs of Abuse and Novel Psychoactive Substances at Outdoor Music Festivals in Colorado

, , , , , & show all

References

  • Charmaz, K. (2006). Constructing grounded theory: A practical guide through qualitative research. London: SagePublications Ltd.
  • Forrester, M. B. (2014). NBOMe designer drug exposures reported to texas poison centers. Journal of Addictive Diseases, 33(3), 196–201.
  • Gladden, R. M., Martinez, P., & Seth, P. (2016). Fentanyl Law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 States, 2013–2014. MMWR. Morbidity and Mortality Weekly Report, 65(33), 837–843. https://doi.org/10.15585/mmwr.mm6533a2
  • González, D., Ventura, M., Caudevilla, F., Torrens, M., & Farre, M. (2013). Consumption of new psychoactive substances in a Spanish sample of research chemical users. Human Psychopharmacology: Clinical and Experimental, 28(4), 332–340. https://doi.org/10.1002/hup.2323
  • Hondebrink, L., Nugteren-van Lonkhuyzen, J. J., Van Der Gouwe, D., & Brunt, T. M. (2015). Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre, 147, 109–115. https://doi.org/10.1016/j.drugalcdep.2014.11.033
  • Hutton, A., Ranse, J., Verdonk, N., Ullah, S., & Arbon, P. (2014). Understanding the characteristics of patient presentations of young people at outdoor music festivals. Prehospital and Disaster Medicine, 29(2), 160–6.
  • Kueppers, V. B., & Cooke, C. T. (2015). 25I-NBOMe related death in Australia: A case report. Forensic Science International. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25747271
  • Lawn, W., Barratt, M., Williams, M., Horne, A., & Winstock, A. (2014). The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology, 28(8), 780–788.
  • Lim, M. S., Hellard, M. E., Hocking, J. S., & Aitken, C. K. (2008a). A cross-sectional survey of young people attending a music festival: associations between drug use and musical preference. Drug Alcohol Review, 27(4), 439–41. https://doi.org/10.1080/09595230802089719
  • Lim, M. S., Hellard, M. E., Hocking, J. S., & Aitken, C. K. (2008b). A cross-sectional survey of young people attending a music festival: associations between drug use and musical preference. Drug Alcohol Review, 27(4), 439–41.
  • McIntyre, I. M., Trochta, A., Gary, R. D., Malamatos, M., & Lucas, J. R. (2015). An acute acetyl fentanyl fatality: A case report with postmortem concentrations. Journal of Analytical Toxicology, 39(6), 490–494. https://doi.org/10.1093/jat/bkv043
  • Miech, R. A., Johnston, L. D., O'malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2015). Monitoring the future national survey results on drug use, 1975–2014.
  • Monte, A. A., Bronstein, A. C., Cao, D. J., Heard, K. J., Hoppe, J. A., Hoyte, C. O., … Lavonas, E. J. (2014). An Outbreak of Exposure to a Novel Synthetic Cannabinoid. New England Journal of Medicine, 370(4), 389–390. https://doi.org/10.1056/NEJMc1313655
  • Moore, K., Dargan, P. I., Wood, D. M., & Measham, F. (2013). Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine. European Addiction Research, 19(5), 276–82.
  • Mowry, J. B., Spyker, D. A., Brooks, D. E., McMillan, N., & Schauben, J. L. (2015). 2014 annual report of the american association of poison control centers' national poison data system (NPDS): 32nd annual report. Clinical Toxicology, 53(10), 962–1147.
  • Munn, M. B., Lund, A., Golby, R., & Turris, S. A. (2016). Observed benefits to on-site medical services during an annual 5-day electronic dance music event with harm reduction services. Prehospital and Disaster Medicine, 1–7. https://doi.org/10.1017/s1049023x16000054
  • Murray, R. A., Doering, P. L., Boothby, L. A., Merves, M. L., McCusker, R. R., Chronister, C. W., & Goldberger, B. A. (2003). Putting an Ecstasy test kit to the test: harm reduction or harm induction? Pharmacotherapy, 23(10), 1238–44.
  • Nelson, M. E., Bryant, S. M., & Aks, S. E. (2014). Emerging drugs of abuse. Emergency Medicine Clinics of North America, 32(1), 1–28.
  • Palamar, J. J., Su, M. K., & Hoffman, R. S. (2016). Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. Am Journal of Drug Alcohol Abuse, 42(1), 39–47.
  • Pourmand, A., Armstrong, P., Mazer-Amirshahi, M., & Shokoohi, H. (2014). The evolving high: new designer drugs of abuse. Human & Experimental Toxicology, 33(10), 993–9. https://doi.org/10.1177/0960327113514100
  • Ridpath, A., Driver, C. R., Nolan, M. L., Karpati, A., Kass, D., Paone, D., … (CDC), C. for D. C. and P. (2014). Illnesses and deaths among persons attending an electronic dance-music festival—New York City, 2013. Morbidity and Mortality Weekly Report, 63(50), 1195–8.
  • Shulgin, A., & Shulgin, A. (1995). PIHKAL: a chemical love story. Berkeley: Transform Press.
  • Shulgin, A., & Shulgin, A. (1997). TIHKAL: tryptamines I have known and loved. Berkeley: Transform Press.
  • Trecki, J., Gerona, R. R., & Schwartz, M. D. (2015). Synthetic cannabinoid–related illnesses and deaths. New England Journal of Medicine, 373(2), 103–107.
  • Vogels, N., Brunt, T. M., Rigter, S., Van Dijk, P., Vervaeke, H., & Niesink, R. J. M. (2016). Content of ecstasy in the Netherlands: 1993–2008. Addiction, 104(12), 2057–2066. https://doi.org/10.1111/j.1360-0443.2009.02707.x
  • Weaver, M. F., Hopper, J. A., & Gunderson, E. W. (2015). Designer drugs 2015: assessment and management. Addiction Science & Clinical Practice, 10(1), 8.
  • Young, A. C., Schwarz, E., Medina, G., Obafemi, A., Feng, S.-Y., Kane, C., & Kleinschmidt, K. (2012). Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation. The American Journal of Emergency Medicine, 30(7), 1320.e5–1320.e7. https://doi.org/10.1016/j.ajem.2011.05.013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.